AMERICAN JOURNAL OF TRANSPLANTATION
metrics 2024
Shaping the future of transplantation with impactful findings.
Introduction
American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
PEDIATRIC TRANSPLANTATION
Advancing pediatric health through innovative transplantation research.Pediatric Transplantation is a prestigious academic journal published by Wiley, focusing on the critical field of pediatric organ transplantation. Since its inception in 1997, the journal has played a pivotal role in disseminating groundbreaking research and clinical insights relevant to pediatric health, including both pediatrics and transplantation disciplines. With an impact factor that reflects its significance—ranking in the second quartile (Q2) within both Pediatrics, Perinatology and Child Health and Transplantation categories—it provides a vital platform for researchers and clinicians dedicated to improving outcomes for pediatric transplant patients. Pediatric Transplantation embraces a wide scope of studies, from basic science to clinical trials, promoting collaborations that enhance the well-being of young organ recipients. Published in the United Kingdom, this journal does not operate under an open access model, ensuring that the content is peer-reviewed and of the highest academic rigor. For professionals and scholars seeking to stay at the forefront of pediatric transplantation advancements, Pediatric Transplantation serves as an invaluable resource.
Journal of Transplantation
Transforming Lives with Groundbreaking Transplant ResearchThe Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.
Transplant Immunology
Illuminating Paths in the Evolving Landscape of Transplant Science.Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.
CLINICAL TRANSPLANTATION
Empowering the Global Transplantation CommunityClinical Transplantation is a leading journal in the field of transplantation medicine, published by Wiley. With an ISSN of 0902-0063 and an E-ISSN of 1399-0012, this prestigious journal has been pivotal in advancing the understanding of clinical practices and innovative research in transplantation since its inception in 1989. Based in the United Kingdom, it is recognized within the Category Quartiles as Q2 in Transplantation and boasts a respectable Scopus rank, placing it #20 out of 54 in its field, highlighting its significance. The journal serves as a platform for disseminating peer-reviewed articles that encompass a wide range of topics, from organ transplantation techniques to post-operative care and immunology, catering to researchers, healthcare professionals, and students alike. As the field progresses towards more personalized and effective treatment approaches, Clinical Transplantation remains committed to providing insight and fostering excellence in research for the global transplantation community.
Transplantation and Cellular Therapy
Unleashing Potential in Cellular Therapy and Transplantation.Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.
Current Opinion in Organ Transplantation
Exploring Innovations in Transplant MedicineCurrent Opinion in Organ Transplantation, published by Lippincott Williams & Wilkins, serves as a leading journal in the fields of immunology and transplantation, providing insightful reviews and expert opinions that shape the discourse in these vital areas of medical research. With an impact factor showcasing its significance and influence in the academic community, this journal is ranked in the Q2 category for both Immunology and Transplantation according to the 2023 metrics, affirming its essential role in advancing knowledge and understanding. Spanning from its inception in 2001 through to 2024, Current Opinion in Organ Transplantation offers a platform for researchers, professionals, and students to engage with the latest advancements and trends, contributing to the ongoing dialogue that drives innovation in organ transplantation and immunological therapies. Although the journal does not currently offer open access options, its rigorous peer-review process and reputable publisher ensure the highest quality of research dissemination, making it an invaluable resource for those invested in the future of organ transplantation.
CELL TRANSPLANTATION
Exploring the future of cell and tissue therapies.CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.
Experimental and Clinical Transplantation
Enhancing Patient Care Through Groundbreaking ResearchExperimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
Elevating Research in Cardiology and Respiratory MedicineJOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.
Seminars in Thoracic and Cardiovascular Surgery
Empowering Innovation in Surgical ExcellenceSeminars in Thoracic and Cardiovascular Surgery, published by Elsevier Inc, is a prestigious journal that focuses on advancing the fields of thoracic and cardiovascular surgery, cardiology, and pulmonary medicine. With a strong impact factor and an impressive reputation indicated by its 2023 rankings as Q2 in Cardiology and Cardiovascular Medicine, and Q1 in both Medicine (miscellaneous) and Surgery, the journal occupies a critical space in the academic landscape. Established in 1989, it has become a vital resource for researchers, clinicians, and students alike, fostering innovation through comprehensive reviews and cutting-edge studies. Although it does not offer open access, its robust editorial standards ensure that published articles contribute significantly to the ongoing discourse in surgical techniques and procedural advancements. Researchers and practitioners are encouraged to explore its rich compendium of peer-reviewed content that informs clinical practices and guides future investigations in the dynamic and evolving realm of thoracic and cardiovascular health.